-
Article
Open AccessOptimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
Radioligand therapy (RLT) with lutetium (177Lu) oxodotreotide is an approved therapy in combination with somatostatin analogues (SSAs) for patients with advanced, well-differentiated G1–G2, gastro-entero-pancreat...
-
Article
Open AccessTerapia del carcinoma corticosurrenalico dopo fallimento del mitotane
Il mitotane rappresenta l’unico farmaco approvato con specifica attività citotossica sulle cellule della corticale del surrene. Viene utilizzato nella terapia medica del carcinoma corticosurrenalico (ACC) nel ...
-
Article
Open AccessMaintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
Whether or not androgen receptor (AR) axis could still be targetable in castration resistant prostate cancer (CRPC) patients with disease progression to next generation hormonal agents (NGHAs) is a controversi...
-
Article
Open AccessSupportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen
The management of patients with advanced/metastatic adrenocortical carcinoma (ACC) is challenging, EDP-M (etoposide, doxorubicin, cisplatin combined with mitotane) is the standard regimen. However, it is quite...
-
Article
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021
-
Article
Open AccessFGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma
FGF/FGFR signaling regulates embryogenesis, angiogenesis, tissue homeostasis and wound repair by modulating proliferation, differentiation, survival, migration and metabolism of target cells. Understandably, c...
-
Article
Open AccessDifferent management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?
Pediatric and adult adrenocortical carcinomas differ in many respects but treatment is often similar in both age groups. The Journal of Clinical Oncology recently published the results of a risk-stratified single...
-
Article
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy
-
Article
Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome